期刊文献+

普萘洛尔对盐酸二甲双胍大鼠肾排泄的影响

Effects of co-administration of propranolol on the renal excretion of metformin hydrochloride in rats
原文传递
导出
摘要 目的:考察普萘洛尔对盐酸二甲双胍肾排泄的影响。方法:20只健康Wistar雄性大鼠随机分为2组,一组尾静脉注射盐酸二甲双胍和普萘洛尔,另一组注射盐酸二甲双胍,于给药后收集各时间段(0~2,2~4,4~6,6~8,8~10,10~12,12~24 h)的尿液样品。用高效液相色谱法测定二甲双胍尿药浓度,用DAS 2.0软件计算二甲双胍的药动学参数后对数据进行分析。结果:联合用药组的药动学参数t1/2,Ke[(2.8±0.4)h,(0.25±0.58)h-1]较二甲双胍组[(2.11±0.30)h,(0.34±0.45)h-1]存在统计学差异(P<0.05),但总尿排量较二甲双胍组无显著性差异(P>0.05)。结论:普萘洛尔对健康Wistar雄鼠盐酸二甲双胍的肾排泄速率有显著影响,可能与其竞争性抑制了肾脏rOCT2有关。 OBJECTIVE To study the effects of co-administration of propranolol on the renal excretion of metformin hydro- chloride in rats. METHODS 20 young male rats were randomly divided into 2 equal groups. After the rats of the co-administra- tion group treated with both propranolol and metformin hydrochloride, metformin hydrochloride group were treated only with metformin hydrochloride via tail vein injection, the urine samples were collected in 0 - 2,2 - 4,4 - 6,6 - 8,8 - 10,10 - 12 and 12 - 24 h. The concentrations of metformin hydrochloride in urine were determined by high performance liquid chromatography. According to the concentration of urine, the software of DAS 2. 0 was used to calculate the pharmacokinetic parameters. RE- SULTS The significantly changed pharmacokinetic parameters of the metformin group and the testing group (P〈0. 05) in rats:t1/2 were (2.8 ± 0.4) and (2. 11 ± 0. 30) h,respectively;Ke were (0. 25 ± 0. 58) and (0. 34 ± 0.45) h^-1 respectively;while the total urine discharge of metformin was not significantly changed (P〉0.05). CONCLUSION Propranolol had significanl effect on the renal excretion process of metformin hydrochloride in rats; the possible reason was that propranolol may competi- tively inhibit renal rOCT2 in rats.
出处 《中国医院药学杂志》 CAS CSCD 北大核心 2013年第11期868-870,共3页 Chinese Journal of Hospital Pharmacy
关键词 普萘洛尔 盐酸二甲双胍 大鼠 肾排泄 rOCT2 propranolol metformin hydrochloride rat renal excretion rOCT2
  • 相关文献

参考文献7

  • 1高会敏,蒙碧辉.1型糖尿病发病机制的研究进展[J].医学研究志,2009,38(1):4-7.
  • 2Fonseca V, Bakris GI., Bell DS,et al. Differential effect of beta blocker therapy on insuin resistance as a function of insulin sensitizer use: results from GEMINI[J].Diabet Med, 2007,24 : 759 -763.
  • 3Kimura N, Masuda S, Tanihara Y,et al. Metformin is a superi- or substrate for renal organic cation transporter (-)CT2 rather than hepatic OCT1 [J].Drug Metab Pharm, 2005,20 (5) : 379- 386.
  • 4Kimura N,Okuda M, Inui K,et al. Metformin transport by re nal basolateral organic cation transporter hOCT2[J]. Pharm tes,2005,22(2) :255- 259.
  • 5Dudley AJ, Bleasby K, Brown CD. The organic cation trans- porter OCT2 mediates the uptake of adrenoceptor antago- nists across the apical membrane of renal I.LC-PK1 cell mono layers[J]. British J Pharmacol,2000,131 : 71-79.
  • 6Silva FG. The aging kidney: A review Part [J]. Int Urol Nephrol,2005,37:419-432.
  • 7Trinh Trang Tan MM,Geelen G,Teillet L, et al. Urea transporter expression in aging kidney and brain during dehydration[J]. Am J Physiol Regul lntegr Comp Physiol, 211113,285 : 1355 -1365.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部